Medicine and Dentistry
Age
12%
Antiangiogenic Therapy
16%
Antineoplastic Activity
16%
Association
13%
Biological Marker
29%
Cancer Cell
27%
Cancer Model
16%
Cancer Recurrence
17%
Cells
22%
Chemotherapeutic Agent
11%
Chemotherapy
18%
Colon Cancer
33%
Colorectal Cancer
80%
Combination Therapy
66%
Comprehension
11%
Development
11%
Diseases
17%
Drug
11%
Enzalutamide
16%
Epidermal Growth Factor Receptor
12%
Fluorouracil
28%
Gender
24%
Gene Expression
20%
Histone Deacetylase Inhibitor
16%
Hypoxia
16%
Inpatient
29%
Interleukin 8
21%
Lapatinib
16%
Malignant Neoplasm
24%
Mediator
11%
Metastatic Carcinoma
31%
Metastatic Colorectal Cancer
27%
Molecular Marker
14%
Mutant
17%
Neoplasm
45%
Oxaliplatin
22%
Patient
100%
Prognosis
11%
Programmed Cell Death
19%
Prostate Cancer
69%
Radiation Therapy
16%
Recurrent Disease
14%
Surgery
11%
Survival
16%
Targeted Therapy
12%
Therapeutic Procedure
74%
Thymidylate Synthase
20%
Tumor Cell
13%
Tumor Microenvironment
22%
Tumor Progression
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antitumor Activity
25%
Apoptosis
27%
Bevacizumab
10%
Biological Marker
25%
Cancer Model
16%
Cancer Recurrence
9%
Capecitabine
17%
Chemokine Receptor CXCR2
9%
Chemotherapy
45%
Colon Cancer
57%
Colorectal Cancer
51%
Cyclin D1
16%
Diseases
16%
DNA
24%
Drug
12%
Enzalutamide
16%
Epidermal Growth Factor Receptor
17%
Fluoropyrimidine
13%
Fluorouracil
38%
Histone
12%
Histone Deacetylase Inhibitor
26%
Hypoxia
16%
Interleukin 8
11%
Irinotecan
9%
Lapatinib
33%
Lethality
9%
Malignant Neoplasm
22%
Metastasis
23%
Metastatic Colorectal Cancer
34%
Neoplasm
41%
Overall Survival
11%
Oxaliplatin
26%
Panobinostat
26%
Prognosis
11%
Progression Free Survival
9%
Prostate Cancer
37%
Protein P53
9%
Receptor
11%
Recurrent Disease
15%
Relapse
9%
Stomach Cancer
24%
Survival
16%
Thymidine Phosphate
9%
Thymidylate Synthase
28%
Toxicity
16%
Tumor Growth
19%
Tumor Microenvironment
12%
Tumor Recurrence
12%
Uracil
8%
Vorinostat
26%
Biochemistry, Genetics and Molecular Biology
Allele
17%
Angiogenesis
26%
Antineoplastic Activity
16%
Apoptosis
37%
Association
22%
Cancer Cell
48%
Capecitabine
9%
Catenin
16%
Cetuximab
16%
Colon
59%
Cyclin D1
16%
Deoxyuridine
24%
Development
12%
DNA
24%
DNA Damage
10%
Endoplasmic Reticulum Stress
16%
Epidermal Growth Factor Receptor
10%
Estrogen Receptor
12%
Fluorouracil
17%
Gender
10%
Gene Expression
22%
Genetic Divergence
18%
Genotyping
18%
Germline
33%
Growth
13%
Histone Deacetylase
10%
Interleukin 8
14%
Kinase
10%
KRAS
25%
Lapatinib
16%
Mediator
11%
Metabolic Pathway
11%
Mutant
26%
Mutation
17%
Nested Gene
52%
Overall Survival
11%
P53
16%
Poly ADP Ribose Polymerase
9%
Polymerase Chain Reaction
10%
Protein
18%
Radiation
9%
Regulatory Mechanism
11%
Sample
15%
Small Interfering RNA
10%
Survival
14%
Thymidylate Synthase
13%
Time
17%
Unfolded Protein Response
16%
Uracil
17%
Wild Type
10%
